{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T12:31:47Z","timestamp":1717072307597},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00115-017-0447-3","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T16:00:34Z","timestamp":1509724834000},"page":"1358-1366","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Spinale Muskelatrophie"],"prefix":"10.1007","volume":"88","author":[{"given":"K.","family":"Vill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blaschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Olgem\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie C.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"447_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, Flynn K, Hendrickson BC, Scholl T, Sirko-Osadsa DA et al (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of \u300972,400 specimens. Eur J Hum Genet 20:27\u201332. https:\/\/doi.org\/10.1038\/ejhg.2011.134","journal-title":"Eur J Hum Genet"},{"key":"447_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS (2007) Spinal muscular atrophy: clinical classification and disease heterogeneity. J\u00a0Child Neurol 22:946\u2013951. https:\/\/doi.org\/10.1177\/0883073807305673","journal-title":"J. Child Neurol."},{"key":"447_CR3","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","volume":"4","author":"E Hahnen","year":"1995","unstructured":"Hahnen E, Forkert R, Marke C, Rudnik-Schoneborn S, Schonling J, Zerres K, Wirth B (1995) Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 4:1927\u20131933","journal-title":"Hum. Mol. Genet."},{"key":"447_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16:265\u2013269. https:\/\/doi.org\/10.1038\/ng0797-265","journal-title":"Nat Genet"},{"key":"447_CR5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6:1205\u20131214","journal-title":"Hum. Mol. Genet."},{"key":"447_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/joa.12083","volume":"224","author":"M Shababi","year":"2014","unstructured":"Shababi M, Lorson CL, Rudnik-Schoneborn SS (2014) Spinal muscular atrophy: a\u00a0motor neuron disorder or a\u00a0multi-organ disease? J\u00a0Anat 224:15\u201328. https:\/\/doi.org\/10.1111\/joa.12083","journal-title":"J Anat"},{"key":"447_CR7","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1093\/hmg\/ddu142","volume":"23","author":"JG Boyer","year":"2014","unstructured":"Boyer JG, Deguise MO, Murray LM, Yazdani A, De Repentigny Y, Boudreau-Lariviere C, Kothary R (2014) Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. Hum Mol Genet 23:4249\u20134259. https:\/\/doi.org\/10.1093\/hmg\/ddu142","journal-title":"Hum. Mol. Genet."},{"key":"447_CR8","unstructured":"Blaschek\u00a0AV, Vill\u00a0K, M\u00fcller-Felber\u00a0W (2017) Aktuelle Entwicklungen in der Therapie der spinalen Muskelatrophie. Kinder- und Jugendarzt 48.(66.) Jahr, Heft 10\/2017: in Druck"},{"key":"447_CR9","doi-asserted-by":"publisher","first-page":"45476","DOI":"10.1074\/jbc.M107632200","volume":"276","author":"SR Lim","year":"2001","unstructured":"Lim SR, Hertel KJ (2001) Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3\u2019 splice site pairing. J\u00a0Biol Chem 276:45476\u201345483. https:\/\/doi.org\/10.1074\/jbc.M107632200","journal-title":"J Biol Chem"},{"key":"447_CR10","doi-asserted-by":"publisher","first-page":"e33572","DOI":"10.1371\/journal.pone.0033572","volume":"7","author":"TO Crawford","year":"2012","unstructured":"Crawford TO, Paushkin SV, Kobayashi DT, Forrest SJ, Joyce CL, Finkel RS, Kaufmann P, Swoboda KJ, Tiziano D, Lomastro R et\u00a0al (2012) Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. PLOS ONE 7:e33572. https:\/\/doi.org\/10.1371\/journal.pone.0033572","journal-title":"PLOS ONE"},{"key":"447_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, Aloysius A, Morrison L, Main M, Crawford TO et\u00a0al (2007) Consensus statement for standard of care in spinal muscular atrophy. J\u00a0Child Neurol 22:1027\u20131049. https:\/\/doi.org\/10.1177\/0883073807305788","journal-title":"J. Child Neurol."},{"key":"447_CR12","doi-asserted-by":"publisher","unstructured":"Bertini E, Dessaud E, Mercuri E, Muntoni F, Kirschner J, Reid C, Lusakowska A, Comi GP, Cuisset JM, Abitbol JL et\u00a0al (2017) Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type\u00a03 spinal muscular atrophy: a\u00a0randomised, double-blind, placebo-controlled phase\u00a02 trial. Lancet Neurology 16:513\u2013522. https:\/\/doi.org\/10.1016\/S1474-4422(17)30085-6","DOI":"10.1016\/S1474-4422(17)30085-6"},{"key":"447_CR13","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/s0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Yamashita M, Rigo F, Hung G, Schneider E et al (2017) Treatment of infantile-onset spinal muscular atrophy with nusinersen: a\u00a0phase 2, open-label, dose-escalation study. Lancet 388:3017\u20133026. https:\/\/doi.org\/10.1016\/s0140-6736(16)31408-8","journal-title":"Lancet"},{"key":"447_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga CA, Swoboda KJ, Darras BT, Iannaccone ST, Montes J, De Vivo DC, Norris DA, Bennett CF, Bishop KM (2016) Results from a\u00a0phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy. Neurology 86:890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000002445","journal-title":"Neurology"},{"key":"447_CR15","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Yamashita M, Rigo F, Hung G, Schneider E et al (2016) Treatment of infantile-onset spinal muscular atrophy with nusinersen: a\u00a0phase 2, open-label, dose-escalation study. Lancet 388:3017\u20133026. https:\/\/doi.org\/10.1016\/S0140-6736(16)31408-8","journal-title":"Lancet"},{"key":"447_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0883073815627882","volume":"31","author":"M Hache","year":"2016","unstructured":"Hache M, Swoboda KJ, Sethna N, Farrow-Gillespie A, Khandji A, Xia S, Bishop KM (2016) Intrathecal injections in children with spinal muscular atrophy: nusinersen clinical trial experience. J Child Neurol 31:899\u2013906. https:\/\/doi.org\/10.1177\/0883073815627882","journal-title":"J. Child Neurol."},{"key":"447_CR17","unstructured":"Shell R A-ZS, Arnold WD, Rodino-Klapac L, Prior TW, Kotha K, Lowes L, Alfano L, Berry K, Church K, Kissel J, Nagendran S, L\u2019Italien J, Sproule D, Du M, Cardenas J, Burghes A, Foust KD, Meyer K, Likhite S, Kaspar BK, Mendell JR (2017) AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Interim Data Demonstrates Improvements in Survival, Motor Function, and Decreased Dependence on Ventilator Support. Am J Respir Crit Care Med 2017:A2648"},{"key":"447_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AH et\u00a0al (2010) Rescue of the spinal muscular atrophy phenotype in a\u00a0mouse model by early postnatal delivery of SMN. Nat Biotechnol 28:271\u2013274. https:\/\/doi.org\/10.1038\/nbt.1610","journal-title":"Nat. Biotechnol."},{"key":"447_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.nmd.2016.06.459","volume":"26","author":"JK Burns","year":"2016","unstructured":"Burns JK, Kothary R, Parks RJ (2016) Opening the window: the case for carrier and perinatal screening for spinal muscular atrophy. Neuromuscul Disord 26:551\u2013559. https:\/\/doi.org\/10.1016\/j.nmd.2016.06.459","journal-title":"Neuromuscul Disord"},{"key":"447_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ogc.2010.03.001","volume":"37","author":"TW Prior","year":"2010","unstructured":"Prior TW (2010) Spinal muscular atrophy: newborn and carrier screening. Obstet Gynecol Clin North Am 37:23\u201336. https:\/\/doi.org\/10.1016\/j.ogc.2010.03.001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"447_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/ajmg.a.33519","volume":"152A","author":"KJ Swoboda","year":"2010","unstructured":"Swoboda KJ (2010) Seize the day: newborn screening for SMA. Am J Med Genet\u00a0A 152A:1605\u20131607. https:\/\/doi.org\/10.1002\/ajmg.a.33519","journal-title":"Am. J. Med. Genet. A"},{"key":"447_CR22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie R, Susi A (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:338\u2013343","journal-title":"Pediatrics"},{"key":"447_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1954.tb04000.x","volume":"43","author":"H Bickel","year":"1954","unstructured":"Bickel H, Gerrard J, Hickmans EM (1954) The influence of phenylalanine intake on the chemistry and behaviour of a\u00a0phenyl-ketonuric child. Acta Paediatr 43:64\u201377","journal-title":"Acta Paediatr"},{"key":"447_CR24","first-page":"281","volume":"65","author":"JM Wilson","year":"1968","unstructured":"Wilson JM, Jungner YG (1968) Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65:281\u2013393","journal-title":"Bol Oficina Sanit Panam"},{"key":"447_CR25","first-page":"E78","volume":"60","author":"N Kato","year":"2015","unstructured":"Kato N, Sa\u2019Adah N, Ar Rochmah M, Harahap NI, Nurputra DK, Sato H, Sadewa AH, Astuti I, Haryana SM, Saito T et al (2015) SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test. Kobe J Med Sci 60:E78\u201385","journal-title":"Kobe J Med Sci"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0447-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0447-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0447-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T09:17:01Z","timestamp":1659777421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0447-3"}},"subtitle":["Zeit f\u00fcr das Neugeborenenscreening?"],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0447-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}